PMID- 37742791 OWN - NLM STAT- MEDLINE DCOM- 20231106 LR - 20231106 IS - 1521-7035 (Electronic) IS - 1521-6616 (Linking) VI - 256 DP - 2023 Nov TI - Intravenous immunoglobulin in kidney transplantation: Mechanisms of action, clinical applications, adverse effects, and hyperimmune globulin. PG - 109782 LID - S1521-6616(23)00545-4 [pii] LID - 10.1016/j.clim.2023.109782 [doi] AB - Intravenous immunoglobulin (IVIG) has been developed for over 40 years. The mechanisms of action of IVIG are complex and diverse, and there may be multiple mechanisms that combine to influence it. IVIG has been used in kidney transplantation for desensitization, treatment of antibody-mediated rejection, and ABO-incompatible transplantation. and treatment or prevention of some infectious diseases. Hyperimmune globulins such as cytomegalovirus hyperimmune globulin (CMV-IG) and hepatitis B hyperimmune globulin (HBIG) have also been used to protect against cytomegalovirus and hepatitis B virus, respectively. However, IVIG is also associated with some rare but serious adverse effects and some application risks, and clinicians need to weigh the pros and cons and develop individualized treatment programs to benefit more patients. This review will provide an overview of the multiple mechanisms of action, clinical applications, adverse effects, and prophylactic measures of IVIG, and hyperimmune globulin will also be introduced in it. CI - Copyright (c) 2023 Elsevier Inc. All rights reserved. FAU - Hou, Yi-Bo AU - Hou YB AD - Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan 430030, China. FAU - Chang, Sheng AU - Chang S AD - Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan 430030, China. FAU - Chen, Song AU - Chen S AD - Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan 430030, China. FAU - Zhang, Wei-Jie AU - Zhang WJ AD - Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan 430030, China. Electronic address: wjzhangtj@126.com. LA - eng PT - Journal Article PT - Review DEP - 20230922 PL - United States TA - Clin Immunol JT - Clinical immunology (Orlando, Fla.) JID - 100883537 RN - 0 (Immunoglobulins, Intravenous) SB - IM MH - Humans MH - Immunoglobulins, Intravenous/adverse effects MH - *Kidney Transplantation MH - *Cytomegalovirus Infections MH - Cytomegalovirus OTO - NOTNLM OT - Adverse effect OT - Hyperimmune globulin OT - Intravenous immunoglobulin OT - Kidney transplantation OT - Mechanism of action EDAT- 2023/09/25 00:42 MHDA- 2023/11/06 06:42 CRDT- 2023/09/24 19:15 PHST- 2023/07/24 00:00 [received] PHST- 2023/09/11 00:00 [revised] PHST- 2023/09/20 00:00 [accepted] PHST- 2023/11/06 06:42 [medline] PHST- 2023/09/25 00:42 [pubmed] PHST- 2023/09/24 19:15 [entrez] AID - S1521-6616(23)00545-4 [pii] AID - 10.1016/j.clim.2023.109782 [doi] PST - ppublish SO - Clin Immunol. 2023 Nov;256:109782. doi: 10.1016/j.clim.2023.109782. Epub 2023 Sep 22.